Medical Services International Signs Agreement with US Biotech Firm to Begin Approval Process in the United States For The VScan
27 Agosto 2007 - 12:57AM
PR Newswire (US)
EDMONTON, Alberta, Aug. 26 /PRNewswire-FirstCall/ -- Medical
Services International Inc. (Pink Sheets: MSITF) wishes to announce
that it has signed an agreement with a US biotech firm based in New
Jersey that specializes in developing new products. As part of the
agreement this firm will be responsible for the completion of all
necessary US testing required that hasn't been completed and filing
of documents necessary to get the VScan TB and VScan Hepatitis C
approved for use in the United States as medical device. This firm
will be responsible for obtaining regulatory approval, marketing
and distribution of the two VScan test kits. Their marketing
program indicates that they will sell in excess of 3.5 million kits
over a two year period once regulatory approval is obtained. They
have also received the option to obtain regulatory approval and
market other VScan products in the United States. Such options are
based on very strict performance criteria. About VScan The VScan
rapid test kit is a single use, easy to use, test for the screening
of HIV1&2, Hepatitis B&C, Tuberculosis (TB),Dengue Fever,
Malaria, West Nile, Syphilis and Prostate Cancer. The kits cannot
be sold in Canada. Medical Services International Inc. trades in
the United states on the NQB Pink Sheets under the symbol "MSITF".
For further information, please contact Robert Talbot at (780) 430
6363 or http://www.medicalservicesintl.com/ or
http://www.minerva-biotech.com/. NOTE: Certain statements in this
press release are "forward-looking statements" within the meaning
of the Private Securities Act of 1995. Such statements involve
known and unknown risks, uncertainties and other factors that may
cause results to differ materially. Such risks, uncertainties and
other factors include but are not limited to new economic
conditions, risk in product development, market acceptance of new
products and continuing market demand, level of competition and
other factors described in Company reports and other filings with
regulatory bodies. DATASOURCE: Medical Services International Inc.
CONTACT: Robert Talbot of Medical Services International Inc.,
+1-780-430-6363 Web site: http://www.medicalservicesintl.com/
Copyright